Barclays analyst Hassan Al-Wakeel raised the firm’s price target on Fresenius Medical to EUR 38 from EUR 36 and keeps an Equal Weight rating on the shares.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on FMS:
- Fresenius Medical price target raised to EUR 54 from EUR 50.90 at Berenberg
- Fresenius Medical price target raised to EUR 38 from EUR 28.60 at JPMorgan
- Fresenius Medical resumed with a Neutral at Citi
- Fresenius Medical price target raised to $28 from $26 at Truist
- Fresenius Medical initiated with a Buy at Goldman Sachs